ArticleAlpha psychiatry2026
Age-Dependent Corpus Callosum Thickness Abnormalities and Clinical Implications in Treatment-Naïve First-Episode Schizophrenia.
Article in Alpha psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although morphological abnormalities of the corpus callosum (CC) have been reported in schizophrenia, findings across studies have been inconsistent. We systematically examined whether these morphological alterations are influenced by age. Methods: A total of 151 individuals with treatment-naïve first-episode schizophrenia (FES) and 278 healthy controls were included. T1-weighted structural MRI scans were used to segment the CC on the midsagittal plane into 100 equidistant points, and CC thickness was estimated at each point. To determine whether CC thickness abnormalities associated with schizophrenia were moderated by age, we applied the Johnson-Neyman technique. Additionally, we investigated the relationship between age-dependent CC thickness abnormalities and clinical symptoms using partial least-squares correlation analysis. Results: Abnormal CC thickness was observed in individuals with treatment-naïve FES, specifically within the rostral body, anterior midbody, isthmus, and splenium. These regions were thinner in younger patients compared with healthy controls but appeared thicker in older patients. Furthermore, increased CC thickness in older patients was associated with greater clinical symptom severity, whereas this association was not observed in younger patients. Conclusions: Our findings demonstrate that CC thickness abnormalities in treatment-naïve FES are age-dependent. The relationship between CC thickness and symptom severity also varies as a function of age. These results suggest that the CC may represent a critical biological target for age-sensitive, individualized therapeutic interventions in schizophrenia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.